mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.01 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.01 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |